Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
792,553,191
-
Total 13F shares
-
90,226,943
-
Share change
-
+33,088,323
-
Total reported value
-
$304,106,740
-
Put/Call ratio
-
120%
-
Price per share
-
$3.37
-
Number of holders
-
64
-
Value change
-
+$110,829,354
-
Number of buys
-
46
-
Number of sells
-
17
Institutional Holders of Mereo BioPharma Group plc - Ordinary Shares (MREO) as of Q1 2021
As of 31 Mar 2021,
Mereo BioPharma Group plc - Ordinary Shares (MREO) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,226,943 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Point72 Asset Management, L.P., BAKER BROS. ADVISORS LP, SUVRETTA CAPITAL MANAGEMENT, LLC, BOXER CAPITAL, LLC, PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Vivo Capital, LLC, HILLHOUSE CAPITAL ADVISORS, LTD., and Rubric Capital Management LP.
This page lists
64
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.